^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ISA101
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
ISA Pharma
Drug class:
HPV-16 E6 protein inhibitor, HPV-16 E7 protein inhibitor
Related drugs:
Phase 2
ISA Pharmaceuticals
Active, not recruiting
Last update posted :
12/29/2023
Initiation :
11/30/2018
Primary completion :
09/01/2024
Completion :
06/01/2025
PD-L1
|
PD-L1 expression
|
Libtayo (cemiplimab-rwlc) • ISA101
Share
